![Antibodies Cross-Reactive to Influenza A (H3N2) Variant Virus and Impact of 2010–11 Seasonal Influenza Vaccine on Cross-Reactive Antibodies — United States Antibodies Cross-Reactive to Influenza A (H3N2) Variant Virus and Impact of 2010–11 Seasonal Influenza Vaccine on Cross-Reactive Antibodies — United States](https://www.cdc.gov/mmwr/preview/mmwrhtml/figures/m6114a1f.gif)
Antibodies Cross-Reactive to Influenza A (H3N2) Variant Virus and Impact of 2010–11 Seasonal Influenza Vaccine on Cross-Reactive Antibodies — United States
![A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/bf57f49f-ebd3-4ce0-8bc0-bbf88947b5be/emmm202215821-abs-0001-m.jpg)
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine
American Society of Nephrology - Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival New in CJASN: http://asn.kdny.info/qGee50DiB8w | Facebook
One-Step Conjugation Method for Site-Specific Antibody–Drug Conjugates through Reactive Cysteine-Engineered Antibodies | Bioconjugate Chemistry
![Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults | Communications Medicine Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults | Communications Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs43856-021-00012-4/MediaObjects/43856_2021_12_Fig1_HTML.png)
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults | Communications Medicine
![Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121001567-fx1.jpg)
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect
![Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies: Cell Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies: Cell](https://www.cell.com/cms/attachment/6a0af54d-bb65-4cec-aab5-94dd217872dd/fx1_lrg.jpg)
Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies: Cell
![Antibodies | Free Full-Text | Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology Antibodies | Free Full-Text | Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology](https://pub.mdpi-res.com/antibodies/antibodies-11-00048/article_deploy/html/images/antibodies-11-00048-g004.png?1657779540)
Antibodies | Free Full-Text | Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology
![Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike | medRxiv Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/10/28/2021.10.27.21265574/F1.large.jpg)
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike | medRxiv
The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis | PLOS Pathogens
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/18/2020.03.17.995738/F1.large.jpg)
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
![Recombinant Anti-C Reactive Protein antibody [EPR20063-85] - BSA and Azide free (Detector) (ab259540) Recombinant Anti-C Reactive Protein antibody [EPR20063-85] - BSA and Azide free (Detector) (ab259540)](https://www.abcam.com/ps/products/259/ab259540/Images/ab259540-1-benefits-of-recombinant-antibodies.png)
Recombinant Anti-C Reactive Protein antibody [EPR20063-85] - BSA and Azide free (Detector) (ab259540)
![Frontiers | B cells in the balance: Offsetting self-reactivity avoidance with protection against foreign Frontiers | B cells in the balance: Offsetting self-reactivity avoidance with protection against foreign](https://www.frontiersin.org/files/Articles/951385/fimmu-13-951385-HTML-r1/image_m/fimmu-13-951385-g001.jpg)